SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?

Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Renal sympathetic denervation has shown promising early results in treating this condition. The SYMPLICITY HTN-3 is the most recent trial to report the effects of this technique on resistant hypertension. This review discusses this study and its surprising neutral results before ending with an overview of key lessons learned

Who was thrombogenic: the stent or the doctor?

In 1986, when pioneers such as Jacques Puel and Ulrich Sigwart implanted the first coronary Wallstents, no guidelines were available to determine the treatment after stenting. From the experience acquired with mechanical prosthetic heart valves, it was inferred that chronic anticoagulation with coumarins was indicated. When the first cases of subacute occlusion were encountered, the anticoagulation regimen was further reinforced. The use of heparin, dextran, or thrombolytic agents during the procedure followed by warfarin, aspirin, sulphinpyrazone, and dipyridamole did not eliminate subacute thrombosis, which occurred in 18% of the first 117 stents implanted and was responsible for a higher incidence of hemorrhagic complications and prolonged hospital stay

Long-term reproducibility of coronary flow velocity measurements in patients with coronary artery disease

In conclusion, flow velocity measurements repeated after a 6-month interval show a variability, which is larger for baseline velocity and coronary flow reserve. This variability is correlated with the changes in heart rate and can be reduced by a normalization for the cross-sectional area at the site of the measurement (coronary flow) and for the aortic pressure at the time of the measurement (flow resistance)

Volumetric intracoronary ultrasound: a new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis?

Quantitative assessment of atherosclerosis during its natural history and following therapeutic interventions is important, as cardiovascular disease remains the most significant cause of morbidity and mortality in industrial societies. While coronary angiography delineates the vessel lumen, permitting only the indirect determination of atherosclerotic wall changes encroaching upon the lumen, intracoronary ultrasound permits direct plaque assessment and quantification. The angiographic percent diameter stenosis, previously suggested as measure of a maximum confidence approach, is still commonly used to quantify stenosis severity, but the reference segments which are required for angiographic interpolation of the normal vessel dimensions are frequently involved in the general process of atherosclerosis, including progression or regression. Considering also the variability of vascular remodeling during the evolution of atherosclerosis, including compensatory enlargement and paradoxical arterial shrinkage, intracoronary ultrasound appears currently to be the only reliable technique to measure plaque burden and progression or regression of atherosclerosis. However, correct matching of the site of measurement at follow-up with the site of the initial ultrasound study is often difficult to achieve, but is significantly facilitated by the use of volumetric intracoronary ultrasound. This approach permits not only area measurement, but also measurement of plaque volume, which appears to be the ideal measure for quantifying the atherosclerotic plaque, as it is highly reproducible and directly reflects the changes of an entire arterial segment

Genética Molecular e Citogenética

XXXII Congresso Brasileiro de Zoologia, Foz do Iguaçu, 2018. Tema: Desafios e perspectivas para a Zoologia na América LatinaCaderno de Resumos de Trabalhos da Área temática Genética Molecular e Citogenética, do XXXII Congresso Brasileiro de ZoologiaSociedade Brasileira de Zoologia (SBZ) e Universidade Federal da Integração Latino-Americana (Unila

Usefulness of three-dimensional reconstruction for interpretation and quantitative analysis of intracoronary ultrasound during stent deployment.

In conclusion, on-line 3-D ICUS is feasible during stent implantation, more sensitive than 2-D ICUS in the assessment of optimal stent expansion, and requires a shorter time for analysis